Charles S Berkman Insider Trading $LGND LIGAND PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles S Berkman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles S Berkman. Charles S Berkman is VP, Gen. Counsel & Secretary in LIGAND PHARMACEUTICALS INC ($LGND).
Charles S Berkman in LIGAND PHARMACEUTICALS INC
Trading Symbol: LGNDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles S Berkman: VP, Gen. Counsel & Secretary
Holdings: 17,328 shares
Current Value: $1,868,652
Latest Transaction: Mar 08 2012
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Charles S Berkman in LIGAND PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 08 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 15.77 | 106 | 1,671 | 17,328 | 17.4 K to 17.3 K (-0.61 %) |
Mar 08 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 15.76 | 3,500 | 55,160 | 17,434 | 20.9 K to 17.4 K (-16.72 %) |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 14.47 | 9,870 | 142,819 | 9,870 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 14.47 | 15,130 | 218,931 | 15,130 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 5,000 | 0 | 20,934 | 15.9 K to 20.9 K (+31.38 %) |
Jan 06 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | J | 10.09 | 1,238 | 12,491 | 15,934 | 14.7 K to 15.9 K (+8.42 %) |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 10.05 | 4,779 | 48,029 | 4,779 | |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 10.05 | 10,221 | 102,721 | 10,221 | |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 3,000 | 0 | 14,696 | 11.7 K to 14.7 K (+25.65 %) |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 9.75 | 5,000 | 48,751 | 11,696 | 16.7 K to 11.7 K (-29.95 %) |
Jul 01 2010 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | J | 1.24 | 7,500 | 9,308 | 100,177 | 92.7 K to 100.2 K (+8.09 %) |
Feb 17 2010 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 1.66 | 100,000 | 166,000 | 100,000 | |
Feb 17 2010 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 18,000 | 0 | 92,677 | 74.7 K to 92.7 K (+24.10 %) |
Feb 17 2010 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 6,000 | 0 | 61,263 | 55.3 K to 61.3 K (+10.86 %) |
Page: 1